| Clinical management of Ebola virus disease in the United States and Europe TM Uyeki, AK Mehta, RT Davey Jr, AM Liddell, T Wolf, P Vetter, ... New England Journal of Medicine 374 (7), 636-646, 2016 | 389 | 2016 |
| Characteristics and outcomes in patients with COVID-19 and acute ischemic stroke: the global COVID-19 stroke registry G Ntaios, P Michel, G Georgiopoulos, Y Guo, W Li, J Xiong, P Calleja, ... Stroke 51 (9), e254-e258, 2020 | 332 | 2020 |
| Virus-induced senescence is a driver and therapeutic target in COVID-19 S Lee, Y Yu, J Trimpert, F Benthani, M Mairhofer, P Richter-Pechanska, ... Nature 599 (7884), 283-289, 2021 | 232 | 2021 |
| Clinical, Diagnostic, and Treatment Disparities between HIV-Infected and Non-HIV-Infected Immunocompromised Patients with Pneumocystis jirovecii Pneumonia HJF Salzer, G Schäfer, M Hoenigl, G Günther, C Hoffmann, B Kalsdorf, ... Respiration 96 (1), 52-65, 2018 | 184 | 2018 |
| Drug-resistant fungi: an emerging challenge threatening our limited antifungal armamentarium A Arastehfar, T Gabaldón, R Garcia-Rubio, JD Jenks, M Hoenigl, ... Antibiotics 9 (12), 877, 2020 | 153 | 2020 |
| Case definition of chronic pulmonary aspergillosis in resource-constrained settings DW Denning, ID Page, J Chakaya, K Jabeen, CM Jude, M Cornet, ... Emerging infectious diseases 24 (8), 2018 | 130 | 2018 |
| Analysis of cardiopulmonary findings in COVID-19 fatalities: high incidence of pulmonary artery thrombi and acute suppurative bronchopneumonia C Grosse, A Grosse, HJF Salzer, MW Dünser, R Motz, R Langer Cardiovascular pathology 49, 107263, 2020 | 127 | 2020 |
| Treatment of chronic pulmonary aspergillosis: current standards and future perspectives A Alastruey-Izquierdo, J Cadranel, H Flick, C Godet, C Hennequin, ... Respiration 96 (2), 159-170, 2018 | 113 | 2018 |
| Spotlight on isavuconazole in the treatment of invasive aspergillosis and mucormycosis: design, development, and place in therapy JD Jenks, HJF Salzer, J Prattes, R Krause, D Buchheidt, M Hoenigl Drug design, development and therapy, 1033-1044, 2018 | 111 | 2018 |
| Emergence of New Delhi metallo-β-lactamase, Austria G Zarfel, M Hoenigl, E Leitner, HJF Salzer, G Feierl, L Masoud, T Valentin, ... Emerging Infectious Diseases 17 (1), 129, 2011 | 97 | 2011 |
| Posaconazole plasma concentrations and invasive mould infections in patients with haematological malignancies M Hoenigl, RB Raggam, HJF Salzer, T Valentin, A Valentin, ... International journal of antimicrobial agents 39 (6), 510-513, 2012 | 87 | 2012 |
| Rifaximin intake leads to emergence of rifampin-resistant staphylococci T Valentin, E Leitner, A Rohn, I Zollner-Schwetz, M Hoenigl, HJF Salzer, ... Journal of Infection 62 (1), 34-38, 2011 | 73 | 2011 |
| S2k-leitlinie gastrointestinale infektionen und morbus Whipple S Hagel, HJ Epple, GE Feurle, WV Kern, PL Jansen, P Malfertheiner, ... Zeitschrift für Gastroenterologie 53 (05), 418-459, 2015 | 70 | 2015 |
| Lack of risk-awareness and reporting behavior towards HIV infection through needlestick injury among European medical students HJF Salzer, M Hoenigl, HH Kessler, FL Stigler, RB Raggam, KE Rippel, ... International journal of hygiene and environmental health 214 (5), 407-410, 2011 | 70 | 2011 |
| Characterisation of Candida within the Mycobiome/Microbiome of the Lower Respiratory Tract of ICU Patients R Krause, B Halwachs, GG Thallinger, I Klymiuk, G Gorkiewicz, M Hoenigl, ... PloS one 11 (5), e0155033, 2016 | 67 | 2016 |
| Nosocomial outbreak of Klebsiella pneumoniae carbapenemase-producing Klebsiella oxytoca in Austria M Hoenigl, T Valentin, G Zarfel, B Wuerstl, E Leitner, HJF Salzer, J Posch, ... Antimicrobial agents and chemotherapy 56 (4), 2158-2161, 2012 | 66 | 2012 |
| Diagnosis and management of systemic endemic mycoses causing pulmonary disease HJF Salzer, G Burchard, OA Cornely, C Lange, T Rolling, S Schmiedel, ... Respiration 96 (3), 283-301, 2018 | 63 | 2018 |
| Chronic pulmonary aspergillosis update: A year in review A Barac, C Kosmidis, A Alastruey-Izquierdo, HJF Salzer, CPAnet Medical mycology 57 (Supplement_2), S104-S109, 2019 | 62 | 2019 |
| S2k-guideline gastrointestinal infectious diseases and Whipple's disease S Hagel, HJ Epple, GE Feurle, WV Kern, PL Jansen, P Malfertheiner, ... Zeitschrift fur Gastroenterologie 53 (5), 418-459, 2015 | 62 | 2015 |
| Humoral and cellular immune responses in SARS-CoV-2 mRNA-vaccinated patients with cancer M Mairhofer, L Kausche, S Kaltenbrunner, R Ghanem, M Stegemann, ... Cancer Cell 39 (9), 1171-1172, 2021 | 51 | 2021 |
